An innovative NHS test developed in Manchester can help detect if patients with chronic health conditions are not taking their prescribed medications, known as non-adherence, which can often lead to further health problems.
A new drug offers hope for people with hypertrophic cardiomyopathy, the world’s most common inherited heart disease.
The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment.
Researchers at The University of Manchester have found that tracking changes in a protein linked to inflammation after a stroke could help identify people at risk of later memory and thinking problems.
Demonstrating the impact it has made over the past year, the NIHR Manchester Biomedical Research Centre has published a summary of its key outcomes, outputs and progress.
Prof Bernard Keavney, Integrative Cardiovascular Medicine Co-Theme Lead at the NIHR Manchester Biomedical Research Centre, will lead the Centre of Excellence at the University, along with Co-Theme Lead, Professor Maciej Tomaszewski.
Scientists have found genes expressed in human cells harvested from urine are remarkably similar to those of the kidney itself, suggesting they could be an important non-invasive source of information on the kidney.
Researchers are addressing several of the most common causes of death and disability, in our region and nationally, through our Inflammation Cluster. Find out more about the range and impact of our cutting-edge research in the first film of our new Spotlight On series.